Johnson Pharmacare reports huge FY26 loss of Rs 55.7 cr, auditor flags going concern risk
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.8 pts less than Nifty Microcap 250 and 2.0 pts less than its Diversified Commercial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Johnson Pharmacare posted FY26 loss of Rs 55.73 cr against Rs 0.58 cr loss last year, with expenses jumping to Rs 43.04 cr from Rs 0.08 cr. Revenue was nil. Auditor issued a qualified opinion citing non-provision of interest on loans and Ind-AS non-compliance. Auditor flagged the company is not capable of meeting liabilities within one year and reported cash losses of Rs 111.24 cr. Total equity is nearly wiped out at Rs 0.44 cr while borrowings stand at Rs 21.40 cr. Statutory auditors resigned during the year.
Sharp negative reaction likely. Severe going concern risk, near-zero equity, qualified audit opinion, and auditor resignation signal deep financial distress.